X-17376088-TCGGCGGCGG-TCGGCGGCGGCGG

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_001291867.2(NHS):​c.348_350dupGGC​(p.Ala117dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,078,419 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 36 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00027 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.00011 ( 0 hom. 30 hem. )

Consequence

NHS
NM_001291867.2 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.485

Publications

1 publications found
Variant links:
Genes affected
NHS (HGNC:7820): (NHS actin remodeling regulator) This gene encodes a protein containing four conserved nuclear localization signals. The encoded protein functions in eye, tooth, craniofacial and brain development, and it can regulate actin remodeling and cell morphology. Mutations in this gene have been shown to cause Nance-Horan syndrome, and also X-linked cataract-40. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2014]
NHS Gene-Disease associations (from GenCC):
  • Nance-Horan syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant X-17376088-T-TCGG is Benign according to our data. Variant chrX-17376088-T-TCGG is described in CliVar as Likely_benign. Clinvar id is 588878.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-17376088-T-TCGG is described in CliVar as Likely_benign. Clinvar id is 588878.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-17376088-T-TCGG is described in CliVar as Likely_benign. Clinvar id is 588878.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-17376088-T-TCGG is described in CliVar as Likely_benign. Clinvar id is 588878.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 30 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSNM_001291867.2 linkc.348_350dupGGC p.Ala117dup disruptive_inframe_insertion Exon 1 of 9 ENST00000676302.1 NP_001278796.1 Q6T4R5-1
NHSNM_198270.4 linkc.348_350dupGGC p.Ala117dup disruptive_inframe_insertion Exon 1 of 8 NP_938011.1 Q6T4R5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NHSENST00000676302.1 linkc.348_350dupGGC p.Ala117dup disruptive_inframe_insertion Exon 1 of 9 NM_001291867.2 ENSP00000502262.1 Q6T4R5-1
NHSENST00000380060.7 linkc.348_350dupGGC p.Ala117dup disruptive_inframe_insertion Exon 1 of 8 1 ENSP00000369400.3 Q6T4R5-2

Frequencies

GnomAD3 genomes
AF:
0.000272
AC:
30
AN:
110366
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000363
Gnomad AMI
AF:
0.00443
Gnomad AMR
AF:
0.000471
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000875
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000152
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000246
AC:
8
AN:
32481
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000793
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00114
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000759
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000114
AC:
110
AN:
968013
Hom.:
0
Cov.:
31
AF XY:
0.0000977
AC XY:
30
AN XY:
306963
show subpopulations
African (AFR)
AF:
0.000490
AC:
10
AN:
20409
American (AMR)
AF:
0.000721
AC:
12
AN:
16637
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15684
East Asian (EAS)
AF:
0.00117
AC:
26
AN:
22135
South Asian (SAS)
AF:
0.000153
AC:
6
AN:
39292
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
24428
Middle Eastern (MID)
AF:
0.000370
AC:
1
AN:
2701
European-Non Finnish (NFE)
AF:
0.0000662
AC:
52
AN:
786016
Other (OTH)
AF:
0.0000737
AC:
3
AN:
40711
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000272
AC:
30
AN:
110406
Hom.:
0
Cov.:
23
AF XY:
0.000180
AC XY:
6
AN XY:
33392
show subpopulations
African (AFR)
AF:
0.000362
AC:
11
AN:
30399
American (AMR)
AF:
0.000470
AC:
5
AN:
10630
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2620
East Asian (EAS)
AF:
0.000879
AC:
3
AN:
3413
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2670
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5829
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
213
European-Non Finnish (NFE)
AF:
0.000152
AC:
8
AN:
52464
Other (OTH)
AF:
0.00
AC:
0
AN:
1491
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000453

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Mar 28, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nance-Horan syndrome Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NHS: BS2 -

NHS-related disorder Benign:1
Mar 14, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.48
Mutation Taster
=85/15
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587780401; hg19: chrX-17394211; API